Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib

The aim of this study was to determine whether skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma (HCC) that is being treated with sorafenib. We evaluated 40 consecutive HCC patients who received sorafenib treatment. The skeletal muscle cross-sectional area wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Kenji, Takai, Koji, Hanai, Tatsunori, Ideta, Takayasu, Miyazaki, Tsuneyuki, Kochi, Takahiro, Suetsugu, Atsushi, Shiraki, Makoto, Shimizu, Masahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463608/
https://www.ncbi.nlm.nih.gov/pubmed/25927582
http://dx.doi.org/10.3390/ijms16059612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463608/
https://www.ncbi.nlm.nih.gov/pubmed/25927582
http://dx.doi.org/10.3390/ijms16059612

Ejemplares similares